Rexin G

Rexin-G is a gene therapy vector that is used in the treatment of various types of cancer. It is a retroviral vector that has been genetically engineered to carry a gene that is toxic to cancer cells.

Mechanism of Action

Rexin-G works by targeting and destroying cancer cells. The vector is injected into the patient's bloodstream, where it seeks out and binds to cancer cells. Once inside the cancer cell, the vector releases its toxic gene, which causes the cancer cell to die.

Clinical Trials

Rexin-G has been tested in several clinical trials for various types of cancer, including pancreatic cancer, sarcoma, and osteosarcoma. In these trials, Rexin-G has shown promise in slowing the growth of tumors and improving patient survival rates.

Side Effects

Like all treatments, Rexin-G can cause side effects. These can include nausea, vomiting, and fatigue. However, these side effects are generally mild and manageable.

Future Research

Research is ongoing to further understand the potential of Rexin-G in cancer treatment. This includes exploring its use in combination with other treatments, and investigating its effectiveness in treating other types of cancer.

See Also

• Gene therapy
• Cancer treatment
• Clinical trials